Transcenta Holding Limited (HKG:6628)
2.550
+0.390 (18.06%)
At close: Mar 27, 2026
Transcenta Holding Employees
Transcenta Holding had 171 employees as of June 30, 2025. The number of employees decreased by 13 or -7.07% since the number was reported on December 31, 2024.
Employees
171
Change
-13
Growth
-7.07%
Revenue / Employee
60.29K HKD
Profits / Employee
-1.71M HKD
Market Cap
1.15B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 171 | -13 | -7.07% |
| Dec 31, 2024 | 184 | -31 | -14.42% |
| Dec 31, 2023 | 215 | -105 | -32.81% |
| Dec 31, 2022 | 320 | -43 | -11.85% |
| Dec 31, 2021 | 363 | 73 | 25.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cutia Therapeutics | 298 |
| Zhaoke Ophthalmology | 270 |
| 3D Medicines | 183 |
| Immunotech Biopharm | 173 |
| Kintor Pharmaceutical | 136 |
| Beijing Biostar Pharmaceuticals | 131 |
| Sunho Biologics | 128 |
| Wuhan YZY Biopharma | 106 |
Transcenta Holding News
- 3 months ago - Transcenta Collaborates With EirGenix To License HiCB Platform - Nasdaq